Matthew R. Redinbo

17.8k total citations · 9 hit papers
170 papers, 13.1k citations indexed

About

Matthew R. Redinbo is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Matthew R. Redinbo has authored 170 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Molecular Biology, 43 papers in Pharmacology and 31 papers in Genetics. Recurrent topics in Matthew R. Redinbo's work include Gut microbiota and health (35 papers), Pharmacogenetics and Drug Metabolism (34 papers) and Cancer therapeutics and mechanisms (23 papers). Matthew R. Redinbo is often cited by papers focused on Gut microbiota and health (35 papers), Pharmacogenetics and Drug Metabolism (34 papers) and Cancer therapeutics and mechanisms (23 papers). Matthew R. Redinbo collaborates with scholars based in United States, United Kingdom and Netherlands. Matthew R. Redinbo's co-authors include Wim G. J. Hol, James J. Champoux, Lance Stewart, Philip M. Potter, Sridhar Mani, Steven A. Kliewer, Aadra P. Bhatt, Bret D. Wallace, Scott J. Bultman and Ryan E. Watkins and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Matthew R. Redinbo

164 papers receiving 12.9k citations

Hit Papers

Alleviating Cancer Drug Toxicity by Inhibiting a ... 1998 2026 2007 2016 2010 2014 1998 2001 1998 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
    2010 811 citations Bret D. Wallace, Hongwei Wang et al. Science profile →
  2. Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-like Receptor 4
    2014 781 citations Madhukumar Venkatesh, Hongwei Wang et al. profile →
  3. Crystal Structures of Human Topoisomerase I in Covalent and Noncovalent Complexes with DNA
    1998 720 citations Matthew R. Redinbo, Lance Stewart et al. Science profile →
  4. The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity
    2001 609 citations Matthew R. Redinbo et al. Science profile →
  5. A Model for the Mechanism of Human Topoisomerase I
    1998 578 citations Lance Stewart, Matthew R. Redinbo et al. Science profile →
  6. The role of the microbiome in cancer development and therapy
    2017 480 citations Aadra P. Bhatt, Matthew R. Redinbo et al. profile →
  7. Plant “helper” immune receptors are Ca 2+ -permeable nonselective cation channels
    2021 258 citations Pierre Jacob, Nak Hyun Kim et al. Science profile →
  8. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens
    2019 239 citations Samantha M. Ervin, Hao Li et al. Journal of Biological Chemistry profile →
  9. Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut
    2023 95 citations Joshua B. Simpson, Matthew R. Redinbo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew R. Redinbo United States 58 8.1k 2.6k 2.6k 2.0k 1.3k 170 13.1k
Tsuyoshi Yokoi Japan 67 6.2k 0.8× 4.8k 1.8× 7.2k 2.8× 1.0k 0.5× 1.6k 1.2× 369 16.2k
Sridhar Mani United States 57 5.0k 0.6× 3.2k 1.2× 1.8k 0.7× 1.4k 0.7× 518 0.4× 241 10.4k
Per Artursson Sweden 84 8.2k 1.0× 7.5k 2.9× 2.6k 1.0× 880 0.4× 1.2k 1.0× 263 23.5k
William C. Cho China 71 11.4k 1.4× 2.7k 1.0× 1.2k 0.5× 599 0.3× 1.0k 0.8× 556 20.7k
Ah‐Ng Tony Kong United States 77 13.0k 1.6× 1.2k 0.5× 1.6k 0.6× 1000 0.5× 1.1k 0.9× 247 19.2k
José V. Castell Spain 61 5.0k 0.6× 3.2k 1.2× 4.3k 1.7× 646 0.3× 1.0k 0.8× 339 17.7k
Stefano Fiorucci Italy 73 5.7k 0.7× 6.0k 2.3× 1.3k 0.5× 1.6k 0.8× 2.2k 1.7× 355 20.0k
Ian A. Blair United States 69 10.0k 1.2× 2.9k 1.1× 1.4k 0.5× 1.3k 0.6× 1.7k 1.3× 421 21.1k
Peter I. Mackenzie Australia 61 5.7k 0.7× 4.1k 1.6× 7.1k 2.8× 939 0.5× 1.1k 0.8× 199 13.2k
Haiping Hao China 60 6.7k 0.8× 1.7k 0.7× 2.2k 0.9× 530 0.3× 1.1k 0.8× 365 12.5k

Countries citing papers authored by Matthew R. Redinbo

Since Specialization
Citations

This map shows the geographic impact of Matthew R. Redinbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew R. Redinbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew R. Redinbo more than expected).

Fields of papers citing papers by Matthew R. Redinbo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew R. Redinbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew R. Redinbo. The network helps show where Matthew R. Redinbo may publish in the future.

Co-authorship network of co-authors of Matthew R. Redinbo

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew R. Redinbo. A scholar is included among the top collaborators of Matthew R. Redinbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew R. Redinbo. Matthew R. Redinbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Graboski, Amanda L., Joshua B. Simpson, Samuel J. Pellock, et al.. (2024). Advanced piperazine-containing inhibitors target microbial β-glucuronidases linked to gut toxicity. RSC Chemical Biology. 5(9). 853–865. 1 indexed citations
3.
Simpson, Joshua B., et al.. (2023). Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response. Gut Microbes. 15(1). 2203963–2203963. 10 indexed citations
4.
Bodoor, Khaldon, Adam D. Lietzan, Philip F. Hughes, et al.. (2023). Targeting Borrelia burgdorferi HtpG with a berserker molecule, a strategy for anti-microbial development. Cell chemical biology. 31(3). 465–476.e12. 2 indexed citations
5.
Lietzan, Adam D., Joshua B. Simpson, William G. Walton, et al.. (2023). Microbial β-glucuronidases drive human periodontal disease etiology. Science Advances. 9(18). eadg3390–eadg3390. 14 indexed citations
6.
Simpson, Joshua B. & Matthew R. Redinbo. (2022). Multi-omic analysis of host-microbial interactions central to the gut-brain axis. Molecular Omics. 18(10). 896–907. 2 indexed citations
7.
Jacob, Pierre, Nak Hyun Kim, Fei-Hua Wu, et al.. (2021). Plant “helper” immune receptors are Ca 2+ -permeable nonselective cation channels. Science. 373(6553). 420–425. 258 indexed citations breakdown →
8.
Bhatt, Aadra P., Samuel J. Pellock, Kristen A. Biernat, et al.. (2020). Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy. Proceedings of the National Academy of Sciences. 117(13). 7374–7381. 150 indexed citations
9.
Pellock, Samuel J., William G. Walton, Samantha M. Ervin, et al.. (2019). Discovery and Characterization of FMN-Binding β-Glucuronidases in the Human Gut Microbiome. Journal of Molecular Biology. 431(5). 970–980. 22 indexed citations
10.
Ervin, Samantha M., Hao Li, Lauren Lim, et al.. (2019). Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. Journal of Biological Chemistry. 294(49). 18586–18599. 239 indexed citations breakdown →
11.
Jariwala, Parth B., Samuel J. Pellock, Dennis Goldfarb, et al.. (2019). Discovering the Microbial Enzymes Driving Drug Toxicity with Activity-Based Protein Profiling. ACS Chemical Biology. 15(1). 217–225. 59 indexed citations
12.
Biernat, Kristen A., Samuel J. Pellock, Aadra P. Bhatt, et al.. (2019). Structure, function, and inhibition of drug reactivating human gut microbial β-glucuronidases. Scientific Reports. 9(1). 825–825. 74 indexed citations
13.
Yauw, Simon T.K., Roger M. L. M. Lomme, Petra van den Broek, et al.. (2018). Microbial Glucuronidase Inhibition Reduces Severity of Diclofenac-Induced Anastomotic Leak in Rats. Surgical Infections. 19(4). 417–423. 24 indexed citations
14.
Wallace, Bret D. & Matthew R. Redinbo. (2012). Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective. Drug Metabolism Reviews. 45(1). 79–100. 46 indexed citations
15.
Ahmad, Syed Sayeed, et al.. (2011). A High Throughput Assay for Discovery of Bacterial β-Glucuronidase Inhibitors. PubMed. 5. 13–20. 21 indexed citations
16.
Wallace, Bret D., Hongwei Wang, J. E. Scott, et al.. (2010). Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme. Science. 330(6005). 831–835. 811 indexed citations breakdown →
17.
Ortlund, Eric A., Jamie T. Bridgham, Matthew R. Redinbo, & Joseph W. Thornton. (2007). Crystal Structure of an Ancient Protein: Evolution by Conformational Epistasis. Science. 317(5844). 1544–1548. 328 indexed citations
18.
Huang, Haiyan, Hongwei Wang, Joseph Locker, et al.. (2006). Modulating transcriptional control of drug metabolism: A novel paradigm in drug therapeutics. Cancer Research. 66. 210–211. 1 indexed citations
19.
Chrencik, Jill, Alex B. Burgin, Yves Pommier, Lance Stewart, & Matthew R. Redinbo. (2003). STRUCTURAL IMPACT OF THE LEUKEMIA DRUG 1-BETA-D-ARABINOFURANOSYLCYTOSINE (ARA-C) ON THE COVALENT HUMAN TOPOISOMERASE I-DNA COMPLEX. Thermochimica Acta. 434. 1 indexed citations
20.
Redinbo, Matthew R., et al.. (2000). New potential targets for antifungal development. 4(3). 265–296. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsuyoshi Yokoi Breakdown of academic impact, for papers by Sridhar Mani Breakdown of academic impact, for papers by Per Artursson Breakdown of academic impact, for papers by William C. Cho Breakdown of academic impact, for papers by Ah‐Ng Tony Kong Breakdown of academic impact, for papers by José V. Castell Breakdown of academic impact, for papers by Stefano Fiorucci Breakdown of academic impact, for papers by Ian A. Blair Breakdown of academic impact, for papers by Peter I. Mackenzie Breakdown of academic impact, for papers by Haiping Hao
Rankless by CCL
2026